GlassScriptPhysician profile
Manish K Patel
NPI 1942453071
$14,943.90
in general payments reported to CMS, 2019-2025
22 companies · $450 in 2025
The $450 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,236 · 2020: $1,842 · 2021: $643 · 2022: $5,895 · 2023: $3,190 · 2024: $689 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,248 · Travel and Lodging: $2,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,247.65 |
| Travel and Lodging | $2,080.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,388.06 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Aveir, Cardiomems |
| Transmedics, INC. | $2,080.80 | 2023 | Organ Care System |
| Medtronic Vascular, INC. | $1,307.79 | 2019-2020 | |
| Abiomed | $1,140.15 | 2019-2025 | Impella |
| Atricure, INC. | $399.19 | 2021-2023 | |
| Baxter Healthcare | $282.00 | 2019 | |
| Helios Cardio INC | $247.86 | 2024 | |
| Medtronic, INC. | $164.93 | 2021 | |
| Boston Scientific Corporation | $152.78 | 2019-2025 | General - Therapies |
| Edwards Lifesciences Corporation | $136.46 | 2021 | |
| Ethicon US, LLC | $129.03 | 2019-2024 | Prolene |
| Chiesi USA, INC. | $115.03 | 2023 | Cleviprex |
| Smith+Nephew, INC. | $81.52 | 2020-2025 | Versajet, Oasis, Collagenase Santyl |
| Wound Management Technologies, INC | $77.68 | 2019 | |
| Livanova USA, INC. | $65.86 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $46.97 | 2019 | |
| Integra Lifesciences Corporation | $29.09 | 2021 | |
| Angiodynamics, INC. | $24.31 | 2023 | Biosentry Tract Sealant System |
| Cvrx, INC. | $22.54 | 2025 | Barostim Neo System |
| Olympus America INC. | $20.50 | 2022 | |
| Glaxosmithkline, LLC. | $17.07 | 2025 | Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $14.28 | 2023 | Xarelto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Manish Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.